FDA: Weight Loss Drug Possibly Linked to Cancer
Lorcaserin may potentially increase the risk of cancer, according to results from a clinical trial assessing the safety of the weight loss agent.
Diagnosis & Disease Information
Risk Factors for CVD More Common in Postmenopausal Women Who Survived Breast Cancer
Researchers compared the development of specific CVD risk factors in postmenopausal women who survived breast cancer and women without history of breast cancer.
Testicular Cancer Treatment May Increase Risk for Heart Disease in Survivors
Recent research shows that although testicular cancer survivors do not totally conform to the criteria for metabolic syndrome, past treatment with platinum-based chemotherapy increases its prevalence among survivors and may lead to a greater risk for heart disease in this patient population.
Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
Results from the ongoing Platinum Study revealed the prevalence of risk factors for CVD among survivors of testicular cancer who received chemotherapy for their cancer.
- Loading...
Loading...
Next post in Genitourinary Cancer
Loading... 
Loading...